Answers are grounded in this paper and cite their sources.
Spider silk is an archetypal high-performance protein fiber that combines outstanding toughness with biocompatibility and biodegradability. However, the large-scale harvesting of native spidroins remains impractical. Recombinant spider silk proteins (rSSPs) offer a scalable and engineerable alternative to access spidroin-inspired building blocks with tunable sequences, modular architectures, and biofunctionality. Here, we review current rSSP production platforms. From a fiber-centric perspective, we summarize how key processing parameters—such as dope formulation, shear/elongational flow, ion–pH gradients, and post-drawing—govern self-assembly. We explain how these secondary-structure transitions ultimately dictate the hierarchical microstructure and mechanical performance of the fibers. Furthermore, we highlight recent advances in the bioinspired spinning of rSSP fibers and the expansion into fiber-derived formats (e.g., nonwovens, membranes, hydrogels, particles, and porous scaffolds) that leverage textile manufacturability and interfacial design for biomedical applications. Representative applications are systematically categorized into three parallel domains: surgical closures and wound dressings, controlled drug-delivery systems, and tissue engineering, where distinct rSSP architectures and functionalities are explicitly tailored to the regenerative demands of specific organs. Finally, we outline key challenges for translation, including high-yield production of high-molecular-weight spidroins, robust structure–property–function profiling, sterilization stability, and pathways toward scalable manufacturing. Ultimately, this review aims to bridge molecular design, fiber processing, and the biomedical implementation of rSSP-based materials. Schematic overview of spider silk types and representative spidroins, the recombinant production of recombinant spider silk proteins (rSSPs) in representative host systems, and their spinning/processing into fibers and fiber-derived material formats for emerging biomedical applications.
No takes yet. Share an insight, caveat, or question.
Du et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: